Mustafa Samur

633 total citations
28 papers, 502 citations indexed

About

Mustafa Samur is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Mustafa Samur has authored 28 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Mustafa Samur's work include Cancer Treatment and Pharmacology (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Mustafa Samur is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Mustafa Samur collaborates with scholars based in Türkiye and Iran. Mustafa Samur's co-authors include Mustafa Özdoğan, Burhan Savaş, Mehmet Artaç, Hakan Bozcuk, Erkan Çoban, Cenker Eken, Hakan Bozcuk, Mustafa Yıldız, Tomris Özben and Hasan Altunbaş and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Breast Cancer Research and Treatment.

In The Last Decade

Mustafa Samur

26 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mustafa Samur Türkiye 11 259 184 117 63 61 28 502
F A Vlems Netherlands 12 482 1.9× 170 0.9× 53 0.5× 50 0.8× 101 1.7× 14 752
Chia‐Hsun Hsieh Taiwan 16 262 1.0× 325 1.8× 86 0.7× 143 2.3× 110 1.8× 47 724
Deborah Casso United States 10 240 0.9× 62 0.3× 46 0.4× 72 1.1× 28 0.5× 16 468
Sue Gao United States 13 185 0.7× 396 2.2× 47 0.4× 20 0.3× 22 0.4× 20 867
Jill M. Oliveri United States 13 505 1.9× 97 0.5× 112 1.0× 68 1.1× 21 0.3× 23 647
Hakan Bozcuk Türkiye 17 407 1.6× 100 0.5× 50 0.4× 48 0.8× 163 2.7× 58 824
Sihan Song South Korea 11 109 0.4× 123 0.7× 55 0.5× 51 0.8× 32 0.5× 39 382
Jeannette M. Day United States 8 269 1.0× 89 0.5× 43 0.4× 83 1.3× 27 0.4× 12 393
Alan Paciorek United States 8 222 0.9× 83 0.5× 58 0.5× 59 0.9× 25 0.4× 12 459
Eun Mi Nam South Korea 13 182 0.7× 197 1.1× 76 0.6× 57 0.9× 94 1.5× 45 529

Countries citing papers authored by Mustafa Samur

Since Specialization
Citations

This map shows the geographic impact of Mustafa Samur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Samur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Samur more than expected).

Fields of papers citing papers by Mustafa Samur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustafa Samur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Samur. The network helps show where Mustafa Samur may publish in the future.

Co-authorship network of co-authors of Mustafa Samur

This figure shows the co-authorship network connecting the top 25 collaborators of Mustafa Samur. A scholar is included among the top collaborators of Mustafa Samur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mustafa Samur. Mustafa Samur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dìnçol, Dìlek, Abdullah Büyükçelik, Mutlu Doğan, et al.. (2009). Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP. Medical Oncology. 27(3). 942–945. 3 indexed citations
2.
Bozcuk, Hakan, et al.. (2006). Quality of Life in Patients With Advanced Non-Small Cell Lung Cancer. Cancer Nursing. 29(2). 104–110. 23 indexed citations
3.
Özdoğan, Mustafa, Mustafa Samur, Mehmet Artaç, et al.. (2006). Factors Related to Truth-Telling Practice of Physicians Treating Patients with Cancer in Turkey. Journal of Palliative Medicine. 9(5). 1114–1119. 47 indexed citations
4.
Yıldız, Mustafa, Çiler Çelik-Özenci, Ilhan Akan, et al.. (2006). Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein‐1 dependent way: An in vitro study*. Cell Biology International. 30(3). 278–282. 7 indexed citations
5.
Bozcuk, Hakan, Aziz Gümüş, Gülay Özbilim, et al.. (2005). Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.. PubMed. 11(6). HY11–20. 7 indexed citations
6.
Bozcuk, Hakan, Mustafa Samur, Mustafa Özdoğan, et al.. (2004). A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients. International Journal of Clinical Practice. 58(11). 1014–1019. 33 indexed citations
7.
Bozcuk, Hakan, Mustafa Samur, Mustafa Yıldız, et al.. (2004). Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine. 27(2-3). 58–65. 85 indexed citations
8.
Özdoğan, Mustafa, et al.. (2004). ?Do not tell?: what factors affect relatives? attitudes to honest disclosure of diagnosis to cancer patients?. Supportive Care in Cancer. 12(7). 497–502. 66 indexed citations
9.
Samur, Mustafa, Şeyda Karaveli, Hakan Bozcuk, et al.. (2003). A Novel Method of Reporting c-erbB-2 Overexpression: Correlation with Grade But Not with Other Prognostic Parameters in Breast Cancer*. TURKISH JOURNAL OF MEDICAL SCIENCES. 33(6). 363–368. 2 indexed citations
10.
Samur, Mustafa, Mustafa Yıldız, & Mehmet Artaç. (2003). Reevaluation of baseline staging tests in breast cancer; what should be the standard?. 1 indexed citations
11.
Çoban, Erkan, Mustafa Samur, Hakan Bozcuk, & Mustafa Özdoğan. (2003). The Value of CEA and CA 19-9 in Detecting Cancer in a Group of High-Risk Subjects with Gastrointestinal Symptoms. The International Journal of Biological Markers. 18(3). 177–181. 2 indexed citations
12.
Bozcuk, Hakan, et al.. (2002). Does awareness of diagnosis make any difference to quality of life?. Supportive Care in Cancer. 10(1). 51–57. 62 indexed citations
13.
Bozcuk, Hakan, Elif Peştereli, Mustafa Samur, et al.. (2001). Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators. Breast Cancer Research and Treatment. 68(3). 239–248. 27 indexed citations
14.
Samur, Mustafa. (2001). Factors associated with utilization of nonproven cancer therapies in Turkey. Supportive Care in Cancer. 9(6). 452–458. 38 indexed citations
15.
Bayrakçı, Kenan, Yusuf Yıldız, Yener Sağlık, et al.. (2001). Primary lymphoma of bones. International Orthopaedics. 25(2). 123–126. 7 indexed citations
17.
Arıcan, Ali, Fikri İçlı, Hakan Akbulut, et al.. (1999). The effect of two different doses of oral clodronate on pain in patients with bone metastases. Medical Oncology. 16(3). 204–210. 13 indexed citations
18.
Samur, Mustafa, Hakan Akbulut, Selim Erekul, et al.. (1999). The Clinical Value of Flow Cytometric DNA Content Analysis in Patientswith Soft Tissue Sarcomas. Sarcoma. 3(3-4). 171–175. 2 indexed citations
19.
Aydın, Faruk, Ahmet Demirkazık, Fikri İçlı, Hakan Akbulut, & Mustafa Samur. (1998). Effects of High Dose Medroxyprogesterone Acetate on Endogenous Granulocyte Macrophage - Colony Stimulating Factor Secretion and Bone Marrow Cellularity in Patients Under Cytotoxic Chemotherapy. Journal of Chemotherapy. 10(5). 394–398. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026